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Current 
Literature 
Material appearing below is thought to be of particular 
interest to Linacre Quarterly readers because of its 
moral. religious. or philosophic content. The medical 
literature constitutes the primary . but not the sale 
source of such material. Tn general. abstracts are 
intended to reflect the substance of the original article. 
Contributions and commentsfrom readers are invited. 
(£. G. Laforet. M. D .. 170 Middlesex Rd. Chestnut Hill. 
MA 02167.) 
Skrabanek P: Why is preventive medicine 
exempted from ethical constraints? J 
Med Ethics 16:187-190 Dec 1990 
For the past three to four decades 
medical experimentation involving in-
dividual human subjects has been subject 
to fairly stringent regulation. On the other 
hand , human experimentation involving 
whole populations of people- under the 
guise of preventive medicine or health 
promotion- entails no such scrutiny. In 
particular, the issue of informed consent is 
largely ignored in this situation. Further, 
the putative advantages of many "pre-
ventive medicine" programs, such as 
breast self-examination, hypertension 
screening, and cervical cancer screening, 
have yet to be confirmed scientifically. 
Some programs, indeed, may actually 
prove harmful. The ethical norms of 
respect for autonomy, beneficence, non-
maleficence, and justice should be applied 
to preventive medicine and to health 
promotion as rigorously as to other areas 
of medicine. 
Hyman DA: How law killed ethics. 
Perspect Bioi & Med 34:134-151 
Autum 1990 
The ubiquitous and burgeoning in-
trusion of law and lawyers into the 
practice of medicine has inhibited ethical 
discourse almost to the point of dis-
appearance. 
Levine RJ: Institutional review boards. 
(editorial) Brit Med J 298:1268-1269 
13 May 1989 
94 
In both Britain and the United States 
there is a mechanism for overseeing 
research activities from an ethical view-
point. However, Britain lacks the 
governmental regulatory process that 
exists in the United States. Although 
ethical improprieties in British clinical 
research have stimulated a call for reform, 
this should not necessarily be patterned 
after the American system because of 
societal and other differences between the 
two nations. 
Loeb JM, Hendee WR, Smith SJ, 
Schwarz MR: Human vs animal 
rights. In defense of animal research. 
JAMA 262:2716-272017 Nov 1989 
Animal research has been a crucial 
component of medical progress. Oppo-
sition to such activities has escalated to 
embrace not only legislative strictures but 
also terrorist attacks. "The American 
Medical Association recognizes the moral 
obligation of investigators to use al-
ternatives to animals whenever possible, 
and to conduct their research with 
animals as humamely as possible. 
However, it is convinced that depriving 
humans of medical advances by preventing 
research with animals is philosophically 
and morally a fundamentally indefensible 
position." 
Dubler NN, Sidel VW: On research in 
HIV infection and AIDS in correction-
al institutions. Milbank Quart 67:171-
207 1989 
AIDS research among prision inmates 
Linacre Quarterly 
requires additional ethical safeguards 
beyond those already in place for such a 
population. These include issues of 
informed consent, confidentiality, IRB 
review, and minimal risk . 
Lantos JD, Frader J: Extracorporeal 
membrane oxygenation and the ethics 
of clinical research in pediatrics. New 
Eng! J Med 323:409-413 9 Aug 1990 
When the classification of any new 
treatment changes from "experimental" 
to "standard" it raises important legal , 
ethical, and financial considerations. 
Although many insist that only controlled 
prospective clinical trails can validate a 
change in category, in smoe instances such 
an unflexible requirement may be in-
appropriate. This would appear to be the 
case with extracorporeal membrane 
oxygenation (ECMO) as used to treat 
some types of respiratory distress in 
newborns . At the present time there is no 
universal agreement about the role of 
ECM 0 , but " ... a desire for rigid rules and 
for a clear demarcation between standard 
and experimental therapy may be unwise 
and unrealistic. Instead , virtue may lie in 
acknowledging that a degree of un-
certainty is the price we have to pay in 
order not to sacrifice other important 
ethical values." 
May, 1991 
Battin MP: Seven caveats concerning the 
discussion of euthanasia in Holland. 
Perspec/ Bio! & Med 34:73-77 Autumn 
1990 
The practice of euthanasia in the 
Netherlands has been cited with increasing 
frequency in the United States as debate 
on the topic accelerates. However, the 
Dutch experience cannot be validly 
translated to the U.S. without observing 
certain caveats. These include the 
following: 
I. firm data about the Dutch practice 
are not available 
2. there are frequent exaggerations 
3. the issue is clouded by the existence 
of semantic differences (in which, 
e.g., withdrawal of life-sustaining 
treatment is not distinguished from 
active euthanasia) 
4. the status of euthanasia in Nether-
lands law is often misunderstood 
5. the home-oriented delivery of health 
care in Holland stands in contrast to 
the U.S. norm 
6. because of the universality of health 
insurance in the Netherlands cost is 
not a factor in the euthanasia debate 
7. since society in Holla nd is much less 
stratified than in the U.S. there is 
less tendency to abuse euthanasia. 
95 
